S&P 500   4,341.58 (-1.38%)
DOW   34,177.87 (-0.76%)
QQQ   359.08 (-1.50%)
AAPL   174.61 (-0.50%)
MSFT   320.39 (-0.12%)
META   296.86 (-0.94%)
GOOGL   131.03 (-2.03%)
AMZN   129.95 (-3.95%)
TSLA   256.67 (-2.25%)
NVDA   411.62 (-2.55%)
NIO   8.50 (-3.63%)
BABA   84.29 (-1.69%)
AMD   96.21 (-4.12%)
T   15.39 (-1.03%)
F   12.26 (-0.81%)
MU   68.31 (-1.97%)
CGC   0.79 (-9.53%)
GE   113.63 (-1.06%)
DIS   82.68 (+0.15%)
AMC   7.74 (-5.15%)
PFE   32.97 (-1.93%)
PYPL   58.92 (-3.19%)
NFLX   384.59 (-0.44%)
S&P 500   4,341.58 (-1.38%)
DOW   34,177.87 (-0.76%)
QQQ   359.08 (-1.50%)
AAPL   174.61 (-0.50%)
MSFT   320.39 (-0.12%)
META   296.86 (-0.94%)
GOOGL   131.03 (-2.03%)
AMZN   129.95 (-3.95%)
TSLA   256.67 (-2.25%)
NVDA   411.62 (-2.55%)
NIO   8.50 (-3.63%)
BABA   84.29 (-1.69%)
AMD   96.21 (-4.12%)
T   15.39 (-1.03%)
F   12.26 (-0.81%)
MU   68.31 (-1.97%)
CGC   0.79 (-9.53%)
GE   113.63 (-1.06%)
DIS   82.68 (+0.15%)
AMC   7.74 (-5.15%)
PFE   32.97 (-1.93%)
PYPL   58.92 (-3.19%)
NFLX   384.59 (-0.44%)
S&P 500   4,341.58 (-1.38%)
DOW   34,177.87 (-0.76%)
QQQ   359.08 (-1.50%)
AAPL   174.61 (-0.50%)
MSFT   320.39 (-0.12%)
META   296.86 (-0.94%)
GOOGL   131.03 (-2.03%)
AMZN   129.95 (-3.95%)
TSLA   256.67 (-2.25%)
NVDA   411.62 (-2.55%)
NIO   8.50 (-3.63%)
BABA   84.29 (-1.69%)
AMD   96.21 (-4.12%)
T   15.39 (-1.03%)
F   12.26 (-0.81%)
MU   68.31 (-1.97%)
CGC   0.79 (-9.53%)
GE   113.63 (-1.06%)
DIS   82.68 (+0.15%)
AMC   7.74 (-5.15%)
PFE   32.97 (-1.93%)
PYPL   58.92 (-3.19%)
NFLX   384.59 (-0.44%)
S&P 500   4,341.58 (-1.38%)
DOW   34,177.87 (-0.76%)
QQQ   359.08 (-1.50%)
AAPL   174.61 (-0.50%)
MSFT   320.39 (-0.12%)
META   296.86 (-0.94%)
GOOGL   131.03 (-2.03%)
AMZN   129.95 (-3.95%)
TSLA   256.67 (-2.25%)
NVDA   411.62 (-2.55%)
NIO   8.50 (-3.63%)
BABA   84.29 (-1.69%)
AMD   96.21 (-4.12%)
T   15.39 (-1.03%)
F   12.26 (-0.81%)
MU   68.31 (-1.97%)
CGC   0.79 (-9.53%)
GE   113.63 (-1.06%)
DIS   82.68 (+0.15%)
AMC   7.74 (-5.15%)
PFE   32.97 (-1.93%)
PYPL   58.92 (-3.19%)
NFLX   384.59 (-0.44%)
NASDAQ:PPH

VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News

$81.29
-1.04 (-1.26%)
(As of 03:09 PM ET)
Compare
Today's Range
$81.22
▼
$82.00
50-Day Range
$77.33
▼
$83.18
52-Week Range
$66.59
▼
$83.35
Volume
45,477 shs
Average Volume
138,991 shs
Market Capitalization
$381.25 million
Assets Under Management
$435.29 million
Dividend Yield
1.92%
Net Expense Ratio
0.35%
ProfileChartDividendHeadlinesHoldingsOptions ChainShort InterestSocial MediaRatings
PPH stock logo

About VanEck Pharmaceutical ETF (NASDAQ:PPH)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

PPH Price History

PPH ETF News Headlines

September 15, 2023 | stocknews.com
Which of these 3 Pharma Stocks Should You Buy, Hold or Sell?
September 3, 2023 | msn.com
Why is big pharma unmoved despite Medicare pricing threat?
September 21, 2023 | Chaikin Analytics (Ad)
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
August 11, 2023 | au.news.yahoo.com
Pharma ETF (PPH) Hit a 52-Week High
July 6, 2023 | finance.yahoo.com
PPH - VanEck Pharmaceutical ETF
June 29, 2023 | msn.com
Sanofi: EPS Momentum Driven By Dupixent, Vaccines Day On Tap
June 21, 2023 | msn.com
ETFs to Capitalize on Eli Lilly's Buyout of DICE Therapeutics
May 26, 2023 | fool.com
VanEck ETF Trust - VanEck Pharmaceutical ETF (NASDAQ: PPH)
September 21, 2023 | Chaikin Analytics (Ad)
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
May 13, 2023 | nasdaq.com
How the Pharmaceutical Industry Is Using AI
See More Headlines
Receive PPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Van Eck
Fund Name
VanEck Pharmaceutical ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:PPH
Inception Date
12/20/2011
Fund Manager
Hao-Hung Peter Liao, Guo Hua Jason Jin
Web
N/A
Phone
14089961010

Fund Focus

Asset Class
Equity
Benchmark
Market Vectors US Listed Pharmaceutical 25 Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
Global
Number of Holdings
26

Fund Statistics

Assets Under Management
$435.29 million
Average Daily Volume
$190,896.50
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
Van Eck Associates Corporation
Advisor
Van Eck Associates Corporation
Custodian
State Street Bank and Trust Company
Distributor
Van Eck Securities Corporation
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
IMC

Options

Optionable
Optionable
Options Volume
1
Put Options
2
Call Options
1
Short Interest
2,330,000 shs

Miscellaneous

Outstanding Shares
4,690,000
Beta
0.72
Creation Unit
50,000
Creation Fee
$500.00
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

VanEck Pharmaceutical ETF Expenses

TypePPHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.35%0.57%0.53%0.47%0.50%
Other Expenses0.00%0.40%0.52%0.29%0.57%
Total Expense0.35%0.72%0.69%0.56%0.69%
Fee Waiver0.00%-0.51%-0.55%-0.22%-0.59%
Net Expense0.35%0.61%0.59%0.52%0.57%

VanEck Pharmaceutical ETF (PPH) Holdings & Exposure

Top 10 PPH Holdings

PPH Sector Exposure

PPH Industry Exposure

Full Holdings Details













PPH ETF - Frequently Asked Questions

How have PPH shares performed in 2023?

VanEck Pharmaceutical ETF's stock was trading at $77.7408 at the beginning of the year. Since then, PPH stock has increased by 4.5% and is now trading at $81.27.
View the best growth stocks for 2023 here.

How often does VanEck Pharmaceutical ETF pay dividends? What is the dividend yield for VanEck Pharmaceutical ETF?

VanEck Pharmaceutical ETF announced a quarterly dividend on Friday, June 30th. Shareholders of record on Wednesday, July 5th will be given a dividend of $0.3891 per share on Friday, July 7th. This represents a $1.56 annualized dividend and a dividend yield of 1.92%. The ex-dividend date is Monday, July 3rd.
Read our dividend analysis for PPH.

What does PPH invest in?

VanEck Pharmaceutical ETF is a equity fund issued by Van Eck. PPH focuses on health care investments and follows the Market Vectors US Listed Pharmaceutical 25 Index. The fund's investments total to approximately $435.29 million assets under management.

What stocks does VanEck Pharmaceutical ETF hold?

PPH invests in 26 holdings. Some of the stocks in their portfolio include Teva Pharmaceutical Industries (TEVA), AbbVie (ABBV), Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), McKesson (MCK), Sanofi (SNY), Novo Nordisk A/S (NVO), Zoetis (ZTS), AmerisourceBergen (ABC) and Merck & Co., Inc. (MRK).

What is the management fee for VanEck Pharmaceutical ETF?

VanEck Pharmaceutical ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for PPH is 0.35%.

What is Bruce Gordon's approval rating as VanEck Pharmaceutical ETF's CEO?

38 employees have rated VanEck Pharmaceutical ETF Chief Executive Officer Bruce Gordon on Glassdoor.com. Bruce Gordon has an approval rating of 98% among the company's employees. This puts Bruce Gordon in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of VanEck Pharmaceutical ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Pharmaceutical ETF investors own include Bank of America (BAC), Alibaba Group (BABA), AeroVironment (AVAV), Activision Blizzard (ATVI), ARK Innovation ETF (ARKK), Applied Materials (AMAT), Applied Graphene Materials (AGM), Air Canada (AC) and Abbott Laboratories (ABT).

What is VanEck Pharmaceutical ETF's stock symbol?

VanEck Pharmaceutical ETF trades on the NASDAQ under the ticker symbol "PPH."

Who are VanEck Pharmaceutical ETF's major shareholders?

VanEck Pharmaceutical ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Goldman Sachs Group Inc. (23.79%), BNP Paribas Arbitrage SNC (8.55%), Avalon Trust Co (6.10%), Miller Investment Management LP (3.09%), Valicenti Advisory Services Inc. (1.54%) and Royal Bank of Canada (1.16%).

How do I buy shares of VanEck Pharmaceutical ETF?

Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is VanEck Pharmaceutical ETF's stock price today?

One share of PPH stock can currently be purchased for approximately $81.27.

How much money does VanEck Pharmaceutical ETF make?

VanEck Pharmaceutical ETF (NASDAQ:PPH) has a market capitalization of $381.16 million.

How many employees does VanEck Pharmaceutical ETF have?

The company employs 147,000 workers across the globe.

How can I contact VanEck Pharmaceutical ETF?

The company can be reached via phone at 14089961010.

This page (NASDAQ:PPH) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -